Manufacturer
ORION CORP(FINLAND)
Registraction Number
MAL19992996ARZ
Content:
Each film-coated tablet contains:
-Entacapone: 200 mg
Indications:
-Parkinson's Disease: Used as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in adult patients with Parkinson’s disease and end-of-dose motor fluctuations, who cannot be stabilized on those combinations.
Instructions:
Dosage: One 200 mg tablet is taken with each levodopa/dopa decarboxylase inhibitor dose. The maximum recommended dose is 200 mg ten times daily, i.e., 2,000 mg of entacapone.
Administration: Swallow the tablet whole with water. It can be taken with or without food. Follow your doctor's instructions regarding the timing and duration of the medication
Malaysia
